lobbying_activities: 1415053

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1415053	77ebc2d1-8547-48a6-a40b-8893694e722b	Q2	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2013	second_quarter	PHA	Issues relating to the Medicare Prescription Drug Act; issues relating to the Affordable Care Act; issues relating to the Independent Payment Advisory Board; H.R. 1588, "Medicare Drug Savings Act of 2013"; H.R. 1919, "Safeguarding America's Pharmaceutical Act of 2013"; and intellectual property issues.	HOUSE OF REPRESENTATIVES	30000		0	0	2013-07-18T18:31:44.610000-04:00